Factorial Partners, LLC Lantheus Holdings, Inc. Transaction History

Factorial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$10.34 - $15.51 $78,584 - $117,876	-7,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $69,236 - $152,380	7,600 New	7,600 $97 Million
Q1 2019 May 10, 2019	SELL	$14.93 - $25.1 $119,440 - $200,800	-8,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$12.68 - $19.01 $524,952 - $787,014	-41,400 Reduced 83.81%	8,000 $125 Million
Q3 2018 Nov 08, 2018	SELL	$13.1 - $16.35 $150,650 - $188,025	-11,500 Reduced 18.88%	49,400 $739 Million
Q2 2018 Aug 01, 2018	BUY	$13.65 - $18.7 $831,285 - $1.14 Million	60,900 New	60,900 $886 Million

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Factorial Partners, LLC with notifications on news.